Assetmark Inc. trimmed its position in MetLife, Inc. (NYSE:MET – Free Report) by 4.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 18,243 shares of the financial services provider’s stock after selling 867 shares during the quarter. Assetmark Inc.’s holdings in MetLife were worth $1,467,000 as of its most recent filing with the Securities & Exchange Commission.
Other hedge funds have also recently modified their holdings of the company. Brighton Jones LLC boosted its stake in MetLife by 9.0% in the 4th quarter. Brighton Jones LLC now owns 4,240 shares of the financial services provider’s stock worth $347,000 after purchasing an additional 351 shares in the last quarter. OneDigital Investment Advisors LLC boosted its stake in MetLife by 28.3% in the 1st quarter. OneDigital Investment Advisors LLC now owns 9,887 shares of the financial services provider’s stock worth $794,000 after purchasing an additional 2,179 shares during the period. World Investment Advisors boosted its position in shares of MetLife by 21.1% during the 1st quarter. World Investment Advisors now owns 7,189 shares of the financial services provider’s stock valued at $577,000 after acquiring an additional 1,251 shares during the last quarter. Envestnet Asset Management Inc. raised its holdings in MetLife by 3.6% during the 1st quarter. Envestnet Asset Management Inc. now owns 3,006,779 shares of the financial services provider’s stock valued at $241,414,000 after buying an additional 105,376 shares during the period. Finally, Callan Capital LLC bought a new stake in shares of MetLife during the first quarter worth $211,000. Institutional investors own 94.99% of the company’s stock.
Analyst Ratings Changes
MET has been the topic of a number of recent research reports. Cowen reiterated a “buy” rating on shares of MetLife in a research report on Friday, August 22nd. UBS Group cut their price objective on MetLife from $94.00 to $91.00 and set a “buy” rating for the company in a research report on Thursday, August 7th. Wells Fargo & Company boosted their price objective on MetLife from $95.00 to $96.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Morgan Stanley lifted their price target on shares of MetLife from $94.00 to $97.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 7th. Finally, Wolfe Research raised MetLife to a “strong-buy” rating in a report on Tuesday, September 16th. One investment analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $95.18.
MetLife Stock Performance
Shares of NYSE MET opened at $78.81 on Thursday. MetLife, Inc. has a 52-week low of $65.21 and a 52-week high of $89.05. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.57. The stock has a market capitalization of $52.41 billion, a price-to-earnings ratio of 13.36, a PEG ratio of 0.70 and a beta of 0.86. The stock’s fifty day simple moving average is $80.24 and its 200 day simple moving average is $78.77.
MetLife (NYSE:MET – Get Free Report) last announced its quarterly earnings results on Wednesday, November 5th. The financial services provider reported $2.34 earnings per share for the quarter, topping analysts’ consensus estimates of $2.30 by $0.04. The company had revenue of $17.36 billion during the quarter, compared to analysts’ expectations of $18.64 billion. MetLife had a return on equity of 19.88% and a net margin of 5.83%.The business’s quarterly revenue was down 5.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.95 earnings per share. As a group, sell-side analysts forecast that MetLife, Inc. will post 9.65 earnings per share for the current fiscal year.
MetLife Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 9th. Stockholders of record on Tuesday, November 4th will be paid a $0.5675 dividend. This represents a $2.27 annualized dividend and a dividend yield of 2.9%. The ex-dividend date is Tuesday, November 4th. MetLife’s dividend payout ratio is currently 38.47%.
MetLife Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- 3 Cash-Rich Stocks With High Growth Potential Right Now
- Most Volatile Stocks, What Investors Need to Know
- Why Vertical Aerospace Stock Could Double After This Flight Test
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Amazon: Breakout Confirmed—Here’s Where It Could Go Next
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.
